Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vaccine

Summary

This study is being done to determine the safety and tolerability of a new investigational vaccine referred to as VEE IA/B V3526, which may induce production of specific antibodies in vaccinated humans, and may protect them against infection with the Venezuelan Equine Encephalitis (VEE) Virus.

Timeline

Start

2005-07

Primary completion

—

Completion

2006-12

Outcome

Outcome not reported

Stopped (Business): “Funding withdrawn”

Drugs

Indications